BioBusiness.TV |

Vivus Inc. 60sec Pitch

Vivus Inc. 60sec Pitch Leland F. Wilson, President and Chief Executive Officer Website: http://www.vivus.com/ Company Overview VIVUS, Inc. is a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products. The current portfolio includes investigational products addressing obesity, diabetes and sexual health. The pipeline includes: Qnexa(TM), for which is in phase 3 for the treatment of obesity and has completed ...

Cynvec, LLC, 60sec Pitch

Cynvec, LLC, 60sec Pitch Frank D. Stonebanks, President and Chief Executive Officer Website: http://www.cynvec.com/ Company Overview Cynvec is a development stage, NYC based company formed in June 2004 to develop Sindbis-based viral vectors as oncolytic therapeutics, through IP licensed exclusively from NYU. The Sindbis vector system represents a unique, proprietary platform technology for potentially numerous therapeutic and diagnostic applications, both as ...

Cell Therapeutics, Inc. 60sec Pitch

Cell Therapeutics, Inc. 60sec Pitch James A. Bianco, M.D, President and Chief Executive Officer Website: http://www.celltherapeutics.com/ Company Overview Cell Therapeutics Inc. (CTI) develops, acquires and commercializes novel treatments for cancer. Its goal is to build aleading, vertically-integrated biopharmaceutical company with a diversified portfolio of proprietary cancer drugs. Its research and in-licensing activities are focused on identifying new, less toxic and more ...

Acucela Inc. 60sec Pitch

Acucela Inc. 60sec Pitch Ryo Kubota, M.D. Ph.D, Chairman, President & CEO Website: http://www.acucela.com/ Company Overview Acucela Inc. is a clinical-stage biotechnology company focused on developing new drug therapies for blinding eye diseases such as age-related macular degeneration (AMD), Stargardt disease, diabetic retinopathy and retinopathy of prematurity, as well as dry eye. We have proprietary disease-specific assays and technologies to identify ...

MiMedx Group Inc. 60sec Pitch

MiMedx Group Inc. 60sec Pitch Matthew Miller, Executive VP Website: http://www.mimedx.com/ Company Overview MiMedx Group, Inc., (MDXG) is an integrated developer, manufacturer, and marketer of patent protected, spine and orthopedic implants which represent breakthroughs in the treatment of trauma and disease. The company is positioned for rapid growth in revenues and profits. The markets for the specific indications our products address is ...

Newron Pharmaceuticals, SPA, 60sec Pitch

Newron Pharmaceuticals, SPA, 60sec Pitch Luca Benatti, Managing Director and Chief Executive Officer Website: http://www.newron.com/ Company Overview Newron Pharmaceuticals S.p.A. is a biopharmaceutical company focused on novel therapies for diseases of the Nervous System and pain. Newron is undertaking phase III trials with safinamide for the treatment of Parkinson’s disease (PD) in conjunction with its partner, Merck Serono. The Company recently reported excellent ...

Osiris Therapeutics, Inc. 60sec Pitch

Osiris Therapeutics, Inc. 60sec Pitch Randal Mills, Ph.D, President and Chief Executive Officer Website: http://www.osiristx.com/ Company Overview Osiris Therapeutics, Inc. is a leading stem cell therapeutic company focused on developing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas. Prochymal is being evaluated in Phase III clinical trials for three indications, including acute and steroid refractory graft versus ...

Vical Incorporated, 60sec Pitch

Vical Incorporated, 60sec Pitch Vijay B. Samant, President and Chief Executive Officer Website: http://www.vical.com/ Company Overview We research and develop biopharmaceutical products based on our patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. We believe the following areas of research offer the greatest potential for our product development efforts: Vaccines for use in high-risk populations for ...

Synta Pharmaceuticals Corp. 60sec Pitch

Synta Pharmaceuticals Corp. 60sec Pitch Safi R. Bahcall, Ph.D, President and Chief Executive Officer Website: http://www.syntapharma.com/ Company Overview Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. Synta has a unique chemical compound library, an integrated ...

Depomed, Inc. 60sec Pitch

Depomed, Inc. 60sec Pitch Carl Pelzel, President and Chief Executive Officer Website: http://www.depomedinc.com/ Company Overview Depomed, Inc. is a specialty pharmaceutical company with two approved products on the market and other product candidates in its pipeline. The company utilizes its proven, proprietary AcuFormTM drug delivery technology to improve existing oral medications, allowing for extended, controlled release of medications to the upper ...